Under the Radar: Kodiak Shares Surge as Eye Drug Matches Regeneron's — WSJ

By Xavier MartinezShares of Kodiak Sciences surged more than 170% Monday-on pace for its largest one-day increase on record-after the company announced its eye drug matched Regeneron's blockbuster Eylea in a Phase 3 trial.Palo Alto, Calif.-based Kodiak said that more than half of patients with wet…